Vir Biotechnology share price logo

Vir Biotechnology

NASDAQ: VIR

Small Cap

$11.30

-0.45

(-3.83%)

as on

Vir Biotechnology Stock Performance

as on October 31, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $11.18
    $11.84
    downward going graph

    1.06%

    Downside

    4.78%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.82
    $12.00
    downward going graph

    57.39%

    Downside

    6.19%

    Upside

    downward going graph

Vir Biotechnology share price movements today

Previous Close
$11.75
Open
$11.62
Volume
928.9K
Market Cap
$2.0B
Day's Low - High
$11.18 - $11.84
52 Week Low - High
$4.82 - $12.00

Vir Biotechnology Historical Returns

1 Month Return
+ 12.02 %
3 Month Return
+ 38.08 %
1 Year Return
+ 101.86 %
3 Year Return
+ 53.74 %
5 Year Return
-68.38 %

Vir Biotechnology Stock Fundamentals & Key Indicators

Check Vir Biotechnology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-1.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.58%

PE Ratio (TTM)

-6.25

Industry PE ratio

-8.21

PEG Ratio

-0.08

EBITDA

-268.0M

Revenue (TTM)

303.2M

Profit Margin

96.20%

Return On Equity TTM

-29.99%

Vir Biotechnology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vir Biotechnology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$2.0B-68.38%-6.2596.20%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Vir Biotechnology Stock including INR - Dollar returns

The Vir Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Vir Biotechnology investment value today

Current value as on today

₹2,04,516

Returns

₹1,04,516

(+104.52%)

Returns from Vir Biotechnology Stock

₹91,201 (+91.2%)

Dollar Impact

₹13,315 (+13.31%)

Analyst Recommendation on Vir Biotechnology Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Vir Biotechnology. Average target price of $21

Vir Biotechnology Share Price Target

Get share price movements and forecasts by analysts on Vir Biotechnology.

What analysts predicted

46.19%UPSIDE

Target Price

$21

Current Price

$11.3

Analyzed by

5 Analysts

High

$30

Target

$21.00

Low

$18

Vir Biotechnology target price $21, a slight upside of 46.19% compared to current price of $11.3. According to 5 analysts rating.

Indian Investors' Interest in Vir Biotechnology Stock

Search interest for Vir Biotechnology Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Vir Biotechnology Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
56
3
2
12
3
1
0
64
0
238
Gross Profit
51
-1
0
8
0
-1
-2
61
-2
236
Operating Income
-78
-129
-216
-99
-138
-108
-172
-48
-133
74
EBITDA
-73
-125
-213
-96
-135
-105
-169
-45
-130
77
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
4
4
2
2
2
2
2
2
2
2
Income Before Tax
-65
-139
-213
-104
-120
-110
-162
-43
-125
80
Income Tax Expense
0
-1
0
0
0
0
0
0
0
0
Net Income
-65
-138
-213
-104
-120
-110
-163
-42
-125
80
Net Profit Margin
-74.78%
-3320.00%
-8102.86%
-617.54%
-3779.12%
-141.19%
-1144.58%
95.44%
9793.10%
98.83%

Vir Biotechnology Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
10
8
76
1,095
1,615
86
74
68
Gross Profit
-
-
-
-
1,023
1,453
63
58
56
Operating Income
-80
-118
-173
-296
420
833
-661
-523
-468
EBITDA
-80
-115
-168
-287
432
848
-641
-508
-456
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
2
4
8
11
15
19
14
11
Income Before Tax
-80
-116
-174
-298
549
754
-628
-523
-437
Income Tax Expense
-10
0
0
0
21
238
-13
-1
0
Net Income
-69
-115
-174
-298
528
515
-615
-521
-437
Net Profit Margin
-41854.36%
-11447.12%
100.00%
100.00%
53.09%
61.57%
-564.69%
-545.03%
82.92%

Vir Biotechnology Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-65
-138
-213
-104
-120
-110
-163
-42
-125
80
Operating Cash Flow
-109
-77
-171
-87
-78
-120
-167
-25
-132
123
Investing Cash Flow
28
211
118
140
126
56
40
86
11
-197
Financing Cash Flow
0
2
0
1
0
2
0
1
162
78
Change in Cash
-80
136
-52
54
49
-61
-127
61
41
4

Vir Biotechnology Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-69
-115
-174
-298
528
515
-615
-521
-437
Operating Cash Flow
-66
-94
-129
-190
-47
1,663
-778
-446
-391
Investing Cash Flow
-29
-60
-256
-9
-140
-1,193
164
499
310
Financing Cash Flow
271
24
449
529
100
34
7
4
3
Change in Cash
174
-129
63
328
-88
504
-606
57
-77

Global Institutional Holdings in Vir Biotechnology

Check out the Institutions with significant holdings in Vir Biotechnology.

Funds
Holdings
iShares
9.39%
Vanguard
8.16%
VANGUARD INDEX FUNDS
5.77%
SPDR
3.16%
DFA
1.14%

Vir Biotechnology News & Key Events

  • img

    Today's Timeline - 14 October

    Wed, 06:29 PM

    -

    Vir Biotechnology partners with Gilead to develop novel T-cell engagers for solid tumors, with potential payments up to $1.74 billion.

Insights on Vir Biotechnology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, -29.0K → 238.94M (in $), with an average increase of 100.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -125.69M → 80.07M (in $), with an average increase of 257.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, VIR stock has moved up by 11.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 623.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 145.1%

About Vir Biotechnology

Vir Biotechnology, Inc. operates as an immunology company with commercialized products, dedicated to devising therapeutic solutions for the treatment and prevention of significant infectious diseases. Its pipeline features several key candidates: Sotrovimab (branded as Xevudy, or VIR-7832), a neutralizing monoclonal antibody for both treating and preventing SARS-CoV-2 infection; VIR-2218 and VIR-3434, aimed at hepatitis B virus; VIR-2482, targeting the prevention of influenza A virus; and VIR-1111, designed to prevent human immunodeficiency virus. The firm maintains a robust network of strategic partnerships and collaborations. These include grant support from organizations like the Bill & Melinda Gates Foundation and the National Institutes of Health. It holds option and licensing arrangements with entities such as Brii Biosciences Limited, and a collaboration and license agreement with Alnylam Pharmaceuticals, Inc. Further licensing relationships exist with The Rockefeller University and MedImmune, Inc. Collaborations extend to WuXi Biologics and Glaxo Wellcome UK Ltd., alongside a research agreement with GlaxoSmithKline Biologicals SA. Furthermore, Vir has secured a manufacturing contract with Samsung Biologics Co.,Ltd. for SARS-CoV-2 antibodies and a clinical development partnership with Gilead Sciences, Inc. focused on chronic hepatitis B virus. The company, established in 2016, is headquartered in San Francisco, California.
OrganisationVir Biotechnology
Headquarters499 Illinois Street, San Francisco, CA, 94158, US
IndustryBiotechnology
CEOMarianne De Backer

Key Management of Vir Biotechnology

Name

Title

Ms. Vanina de Verneuil J.D.

Executive VP, General Counsel & Corporate Secretary

Dr. Jennifer Eileen Towne Ph.D.

Executive VP & Chief Scientific Officer

Dr. Kiki Patel Pharm.D.

Head of Investor Relations

Ms. Carolyn Wang

Senior Vice President of Corporate Communications

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.

President, CEO & Director

Dr. Lawrence Corey M.D.

Co-Founder & Scientific Advisor

Dr. Louis J. Picker M.D.

Co-Founder & Scientific Advisor

Mr. Aziz Sawaf C.F.A., M.B.A.

Executive VP, CFO & Principal Financial Officer

Mr. Brent Sabatini C.P.A., M.B.A.

Senior VP, Principal Accounting Officer & Chief Accounting Officer

Dr. Maninder Hora Ph.D.

Executive VP & Chief Technical Operations Officer

FAQs

What is Vir Biotechnology share price today?

Vir Biotechnology share price today is $11.30 as on at the close of the market. Vir Biotechnology share today touched a day high of $11.84 and a low of $11.18.

What is the 52 week high and 52 week low for Vir Biotechnology share?

Vir Biotechnology share touched a 52 week high of $12.00 on and a 52 week low of $4.82 on . Vir Biotechnology stock price today i.e. is closed at $11.30,which is 5.83% down from its 52 week high and 134.68% up from its 52 week low.

What is Vir Biotechnology's market capitalisation today?

Vir Biotechnology market capitalisation is $0.00T as on .

How to invest in Vir Biotechnology Stock (VIR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vir Biotechnology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vir Biotechnology Stock (VIR) from India?

Indian investors can start investing in Vir Biotechnology (VIR) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Vir Biotechnology stock (as per the Rupee-Dollar exchange rate as on ). Based on Vir Biotechnology share’s latest price of $11.30 as on October 31, 2026 at 8:45 am IST, you will get 0.8850 shares of Vir Biotechnology. Learn more about fractional shares .

What are the returns that Vir Biotechnology has given to Indian investors in the last 5 years?

Vir Biotechnology stock has given -68.38% share price returns and 27.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?